An update on invasive pneumococcal antibiotic resistance in Turkey, 2008.
Cumulative pneumococcal antibiotic resistance profiles in Turkey in 2008, verified from local studies are as follows: penicillin 35%, cefotaxime 2%, ceftriaxone 1%, trimethoprim-sulfamethoxazole 39%, tetracycline 19%, erythromycin 18%, azithromycin 18%, clarithromycin 10%, ofloxacin 13%, clindamycin 9%, chloramphenicol 5%, rifampicin 2%, levofloxacin 2%, moxifloxacin 0%, gemiloxacin 0%, telithromycin 0%, vancomycin 0%.
Erdem
H
H
Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey. hakanerdem1969@yahoo.com
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013296:Streptococcus pneumoniae; D014421:Turkey
D000900:Anti-Bacterial Agents